BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30630888)

  • 1. New criteria for the omission of lymphadenectomy in endometrioid carcinoma.
    Matsushita C; Fujiwara H; Takei Y; Saga Y; Machida S; Taneichi A; Takahashi S; Yoshiba T; Koyanagi T; Takahashi Y; Morisawa H; Suzuki M
    Int J Gynecol Cancer; 2019 Mar; 29(3):541-546. PubMed ID: 30630888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
    Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
    Akbayir O; Corbacioglu A; Goksedef BP; Numanoglu C; Akca A; Guraslan H; Bakir LV; Cetin A
    Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of lymph node metastasis based on tumor size in stage 1A endometrioid endometrium cancer.
    Avcı F; Can B; Dik B; Gulmez A; Kulhan M; Celik C; Bilgi A
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):214-220. PubMed ID: 38235872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
    Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
    Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
    Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
    Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor diameter as a predictor of lymph node involvement in endometrioid type endometrial adenocarcinomas.
    Akış S; Kabaca C; Keleş E; Öztürk UK; Özyürek E; Api M; Çetiner H; Bostancı E
    J Obstet Gynaecol Res; 2021 Nov; 47(11):3968-3978. PubMed ID: 34378275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer.
    Cox Bauer CM; Greer DM; Kram JJF; Kamelle SA
    Gynecol Oncol; 2016 May; 141(2):199-205. PubMed ID: 26905210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
    Zhu M; Jia N; Huang F; Liu X; Zhao Y; Tao X; Jiang W; Li Q; Feng W
    BMC Cancer; 2017 Oct; 17(1):696. PubMed ID: 29061125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.
    Boren T; Lea J; Kehoe S; Miller DS; Richardson D
    Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
    Mariani A; Dowdy SC; Cliby WA; Gostout BS; Jones MB; Wilson TO; Podratz KC
    Gynecol Oncol; 2008 Apr; 109(1):11-8. PubMed ID: 18304622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
    Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
    Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
    Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
    Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
    Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
    Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.